By Sheeba M. | May 16, 2026
Cannabis MSO Debt Markets Rally as Institutional Capital Returns
The cannabis debt market just sent a signal that Wall Street missed. For the first time since 2022, multi-state operators are tapping capital markets at rates that don’t look like junk financing anymore.
This week alone, three major MSOs accessed institutional debt at spreads that would have been unthinkable six months ago. Curaleaf locked in $150M at 475bp, Green Thumb Industries raised $120M at 425bp, and Cresco Labs completed a $100M facility at 400bp. For context: six months ago, anything under 600bp was considered a win.
What changed? Three things:
1. Profitability metrics are real. Q1 2026 showed the first meaningful margin expansion we’ve seen in 18 months. EBITDA margins at tier-one operators hit 28-32%, and debt/EBITDA ratios are falling. Institutional capital noticed. When Wall Street sees positive FCF growth, credit spreads follow.
2. Schedule III reclassification is de-risking the sector. Banks that avoided cannabis entirely are now opening compliance-first lines. The regulatory overhang that made cannabis debt uninvestable is lifting—not gone, but lifting. That matters for credit pricing.
3. Fed rate cuts are reshaping fixed-income risk appetite. Capital is hunting for yield in the 5-7% range. Cannabis debt at 7.5-8% is suddenly interesting to institutional guys who were locked out of the space for regulatory reasons.
Who Wins?
Trulieve still carries the highest debt load, but this market window helps them refinance $200M+ expiring lines at better rates. Verano Holdings should benefit most—they’re at the right leverage point (2.8x EBITDA) to tap this market without signaling stress. Ascend Wellness is the sneaky winner: smaller but highly profitable, they can now refinance at rates that improve interest expense by 100+ bp annually.
The Downside
Credit spreads don’t stay compressed in this cycle. If the Fed pauses rate cuts or inflation re-accelerates, spreads will widen again. Operators should refinance while windows are open—debt maturity walls in 2027-2028 are going to be real.
The Bottom Line
This isn’t just market noise. MSO debt market recovery signals that Wall Street now believes cannabis profitability is durable. That’s a threshold moment. From a portfolio perspective, it de-risks leverage plays on tier-one operators and signals that balance sheet management is finally working. Watch this space closely—debt market strength often leads equity value creation by 60-90 days.
Sources
- Reuters Cannabis Lending Trends — Institutional debt market dynamics
- Bloomberg: Cannabis MSO Financing Activity — Recent capital raises and spreads
- Financial Times: Capital Markets Recovery — Credit spreads compression
Track cannabis stocks with the Weedstock Real-Time Tracker